Concentration of High-Cost Head and Neck Cancer Surgical Patients

被引:0
|
作者
Garcia, Jordan [1 ]
Yesantharao, Lekha [1 ]
Frick, Kevin D. [2 ,3 ]
Fakhry, Carole [1 ]
Koch, Wayne [1 ]
Mydlarz, Wojtech [1 ]
Eisele, David W. [1 ]
Gourin, Christine G. [1 ,4 ]
机构
[1] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[4] Johns Hopkins Med Inst, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA
来源
LARYNGOSCOPE | 2024年
关键词
cost; high-cost; hospital concentration; hospital concentration head and neck cancer; larynx cancer; Nationwide Inpatient Sample; oral cancer; oropharyngeal cancer; surgery; SURGERY;
D O I
10.1002/lary.31618
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective Health care costs are disproportionately concentrated among a small number of patients. We sought to identify variables associated with high-cost patients and high hospital concentration of high-cost patients and to examine associations with short-term outcomes in head and neck cancer (HNCA) surgery. Study Design The Nationwide Inpatient Sample was used to identify 170,577 patients who underwent HNCA surgery in 2001-2011. High-cost patients were defined as patients whose costs of care were in the top decile, and high-concentration hospitals were defined as those whose percentage of high-cost patients was in the top decile. Methods Multivariable regression was used to evaluate associations between cost and patient and hospital variables, postoperative complications, and in-hospital mortality. Results Costs associated with high-cost patients were 4.47-fold greater than the remaining 90% of patients. High-concentration hospitals treated 36% of all high-cost patients. High-cost patients were more likely to be non-white (OR = 2.08 [1.45-2.97]), have oral cavity cancer (OR = 1.21 [1.05-1.39]), advanced comorbidity (OR = 1.53 [1.31-1.77]), Medicaid (OR = 1.93 [1.62-2.31]) or self-pay payor status (OR = 1.72 [1.38-2.14]), income>50th percentile (OR = 1.25 [1.05-1.51]), undergo major procedures (OR = 3.52 [3.07-4.05]) and have non-routine discharge (OR = 7.50 [6.01-9.35]). High-concentration hospitals were more likely to be teaching hospitals (OR = 3.14 [1.64-6.05]) and less likely to be urban (OR = 0.20 [0.04-0.93]). After controlling for all other variables, high-cost patients were associated with an increased odds of mortality (OR = 8.00 [5.89-10.85]) and postoperative complications (OR = 5.88 [5.18-6.68]). High-concentration hospitals were associated with an increased odds of postoperative complications (OR = 1.31 [1.08-1.61]) but were not associated with increased mortality (OR = 0.98 [0.67-1.44]). Conclusions High-cost HNCA surgical patients are associated with increased postoperative morbidity and mortality, and are disproportionately concentrated at teaching hospitals.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Characteristics and outcome of high-cost ICU patients
    Aung, Yin Nwe
    Nur, Amrizal M.
    Ismail, Aniza
    Aljunid, Syed M.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 505 - 513
  • [22] The Case for Enrolling High-Cost Patients in an ACO
    Graber, Abraham
    Carter, Shane
    Bhandary, Asha
    Rizzo, Matthew
    HEC FORUM, 2017, 29 (04) : 359 - 365
  • [23] Hot Spotting as a Strategy to Identify High-Cost Surgical Populations
    Shubeck, Sarah P.
    Thumma, Jyothi R.
    Dimick, Justin B.
    Nathan, Hari
    ANNALS OF SURGERY, 2019, 269 (03) : 453 - 458
  • [24] What are the drivers of high-cost HIV patients?
    Krentz, Hartmut B.
    Gill, M. John
    INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (11) : 1066 - 1073
  • [25] High surgical volume is associated with improved survival in head and neck cancer
    Rygalski, Chandler J.
    Huttinger, Zachary M.
    Zhao, Songzhu
    Brock, Guy
    VanKoevering, Kyle
    Old, Matthew O.
    Teknos, Theodoros N.
    Rocco, James W.
    Puram, Sidharth V.
    Seim, Nolan B.
    Swendseid, Brian
    Haring, Catherine T.
    Eskander, Antoine
    Kang, Stephen Y.
    ORAL ONCOLOGY, 2023, 138
  • [26] How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies
    Lakdawalla, Darius N.
    Romley, John A.
    Sanchez, Yuri
    Maclean, J. Ross
    Penrod, John R.
    Philipson, Tomas
    HEALTH AFFAIRS, 2012, 31 (04) : 676 - 682
  • [27] ASPIRATION IN HEAD AND NECK SURGICAL PATIENTS
    LOGEMANN, JA
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1985, 94 (04): : 373 - 376
  • [28] Surgical Management of Postradiation, Dropped Head Spinal Deformity in Patients with Head and Neck Cancer
    Verla, Terence
    Vedantam, Aditya
    North, Robert Y.
    Xu, David S.
    Raber, Michael R.
    Fuentes, Alfonso
    Liou, Nelson Eddie
    Ropper, Alexander E.
    WORLD NEUROSURGERY, 2021, 156 : E1 - E8
  • [29] Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences?
    Watters, K
    O'Dwyer, TP
    Rowley, H
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2004, 118 (09): : 694 - 699
  • [30] Improving Surgical and Non-Surgical Oncological Outcomes in Patients with Head and Neck Cancer
    Atkinson, B.
    Wilson, J.
    BRITISH JOURNAL OF SURGERY, 2021, 108